(Q41352112)

29 September 2017

1 reference

title

Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases? (English)

1 reference

29 September 2017

1 reference

1 reference

Cohen AM

1

1 reference

29 September 2017

Kemeny NE

2

1 reference

29 September 2017

Köhne CH

3

1 reference

29 September 2017

Wils J

4

1 reference

29 September 2017

de Takats PG

5

1 reference

29 September 2017

Kerr DJ

6

1 reference

29 September 2017

language of work or name

1 reference

1 December 1996

1 reference

European Journal of Cancer

29 September 2017

published in

1 reference

29 September 2017

volume

32A

1 reference

29 September 2017

issue

13

1 reference

29 September 2017

page(s)

2195-2205

1 reference

Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Regional chemotherapy of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900393-0

7 January 2021

10.1016/S0959-8049(96)00393-0

Identifiers

DOI

1 reference

29 September 2017

1 reference